These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32454217)

  • 1. Purkinje system hyperexcitability and ventricular arrhythmia risk in type 3 long QT syndrome.
    Barake W; Giudicessi JR; Asirvatham SJ; Ackerman MJ
    Heart Rhythm; 2020 Oct; 17(10):1768-1776. PubMed ID: 32454217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
    Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lidocaine attenuation testing: An in vivo investigation of putative LQT3-associated variants in the SCN5A-encoded sodium channel.
    Anderson HN; Bos JM; Kapplinger JD; Meskill JM; Ye D; Ackerman MJ
    Heart Rhythm; 2017 Aug; 14(8):1173-1179. PubMed ID: 28412158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy.
    Laurent G; Saal S; Amarouch MY; Béziau DM; Marsman RF; Faivre L; Barc J; Dina C; Bertaux G; Barthez O; Thauvin-Robinet C; Charron P; Fressart V; Maltret A; Villain E; Baron E; Mérot J; Turpault R; Coudière Y; Charpentier F; Schott JJ; Loussouarn G; Wilde AA; Wolf JE; Baró I; Kyndt F; Probst V
    J Am Coll Cardiol; 2012 Jul; 60(2):144-56. PubMed ID: 22766342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term flecainide therapy in type 3 long QT syndrome.
    Chorin E; Taub R; Medina A; Flint N; Viskin S; Benhorin J
    Europace; 2018 Feb; 20(2):370-376. PubMed ID: 28339995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling tissue- and mutation- specific electrophysiological effects in the long QT syndrome: role of the Purkinje fiber.
    Iyer V; Sampson KJ; Kass RS
    PLoS One; 2014; 9(6):e97720. PubMed ID: 24892747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biology of the long QT syndrome: impact on management.
    Priori SG; Napolitano C; Paganini V; Cantù F; Schwartz PJ
    Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2052-7. PubMed ID: 9272507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant.
    Gando I; Campana C; Tan RB; Cecchin F; Sobie EA; Coetzee WA
    J Mol Cell Cardiol; 2020 Jul; 144():1-11. PubMed ID: 32339567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifocal ectopic purkinje-related premature contractions and related cardiomyopathy.
    Calloe K; Magnusson HBD; Lildballe DL; Christiansen MK; Jensen HK
    Front Cardiovasc Med; 2023; 10():1179018. PubMed ID: 37600057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel gain-of-function mutation in SCN5A responsible for multifocal ectopic Purkinje-related premature contractions.
    Doisne N; Waldmann V; Redheuil A; Waintraub X; Fressart V; Ader F; Fossé L; Hidden-Lucet F; Gandjbakhch E; Neyroud N
    Hum Mutat; 2020 Apr; 41(4):850-859. PubMed ID: 31930659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients.
    Calvillo L; Spazzolini C; Vullo E; Insolia R; Crotti L; Schwartz PJ
    Heart Rhythm; 2014 Jan; 11(1):126-32. PubMed ID: 24135497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic QT response to cold-water face immersion in long-QT syndrome type 3.
    Takahashi K; Shimizu W; Makita N; Nakayashiro M
    Pediatr Int; 2020 Aug; 62(8):899-906. PubMed ID: 32449227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3.
    Iyer V; Roman-Campos D; Sampson KJ; Kang G; Fishman GI; Kass RS
    Sci Rep; 2015 Aug; 5():13287. PubMed ID: 26289036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction.
    Malan D; Zhang M; Stallmeyer B; Müller J; Fleischmann BK; Schulze-Bahr E; Sasse P; Greber B
    Basic Res Cardiol; 2016 Mar; 111(2):14. PubMed ID: 26803770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCN5a overlap syndromes-This episode: Long QT syndrome type 3 meets multifocal ectopic Purkinje-related premature contractions.
    Amin AS
    Heart Rhythm; 2020 Oct; 17(10):1777-1778. PubMed ID: 32497765
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypernatremia and intercalated disc edema synergistically exacerbate long-QT syndrome type 3 phenotype.
    Wu X; Hoeker GS; Blair GA; King DR; Gourdie RG; Weinberg SH; Poelzing S
    Am J Physiol Heart Circ Physiol; 2021 Dec; 321(6):H1042-H1055. PubMed ID: 34623182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of ageing and adrenergic challenge on electrocardiographic phenotypes in a murine model of long QT syndrome type 3.
    Chadda KR; Ahmad S; Valli H; den Uijl I; Al-Hadithi AB; Salvage SC; Grace AA; Huang CL; Jeevaratnam K
    Sci Rep; 2017 Sep; 7(1):11070. PubMed ID: 28894151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac sodium channel mutation associated with epinephrine-induced QT prolongation and sinus node dysfunction.
    Chen J; Makiyama T; Wuriyanghai Y; Ohno S; Sasaki K; Hayano M; Harita T; Nishiuchi S; Yuta Yamamoto ; Ueyama T; Shimizu A; Horie M; Kimura T
    Heart Rhythm; 2016 Jan; 13(1):289-98. PubMed ID: 26282245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic and clinical characteristics of single and compound types of patients with long QT syndrome type 3].
    Zhang ZH; Zuo J; Huang Y; Duan HY; Xia H; Jiang H; Hu D
    Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Jul; 52(7):777-783. PubMed ID: 39019826
    [No Abstract]   [Full Text] [Related]  

  • 20. Eleclazine exhibits enhanced selectivity for long QT syndrome type 3-associated late Na
    El-Bizri N; Xie C; Liu L; Limberis J; Krause M; Hirakawa R; Nguyen S; Tabuena DR; Belardinelli L; Kahlig KM
    Heart Rhythm; 2018 Feb; 15(2):277-286. PubMed ID: 29017927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.